+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

PCR For Respiratory Infection Diagnostic Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type, Multiplex PCR, Traditional PCR, Digital PCR, Reverse-Transcriptase,and Others, Product Type, Infection Type, End Users and Geography

  • PDF Icon

    Report

  • 284 Pages
  • June 2021
  • Region: Global
  • The Insight Partners
  • ID: 5394021
UP TO OFF until Mar 15th 2023
High Prevalence of Breast Cancer Drives Growth of Custom Antibody Market



According to the new research study on “PCR for respiratory infection diagnostics market” Forecast to 2028 - COVID-19 Impact and Global Analysis - by Type, Product Type, Infection Type, End User,” the market is expected to reach US$ 8279.32 million by 2028 from US$ 4,146.02 million in 2021; it is estimated to grow at a CAGR of 10.4% from 2021 to 2028. The report highlights trends prevailing in the market and factors driving its growth. The market growth is mainly attributed to the factors such as the increasing Burden of Chronic Respiratory Diseases (CRDs), growing developments in PCR testing, are widely enhancing the performance of medical devices. However, use of PCR testing for various respiratory infection diagnostics and developments in PCR technology being used to derive them. The availability of alternative assays hinders the market growth.



Chronic respiratory diseases (CRDs) are among the leading causes of morbidity globally. The burden is widely seen globally due to the heavy consumption of tobacco. For instance, according to WHO, in 2018, the fourth largest cause of mortality in the United States was chronic lower respiratory illness, predominantly COPD. Nearly 15.7 million Americans (6.4%) have been diagnosed with COPD. Moreover, according to the European Lung White Book, the World Health Organization (WHO) has reported the European region ranks fourth for fatal lung diseases accounting for nearly one-tenth of all deaths in 2008. Also, in the European Union, ~28 countries, i.e., 12.5% was the proportion of deaths due to respiratory diseases. In addition, in 2008, the European Respiratory Society (ERS) reported ~6 million hospital admissions due to respiratory diseases, accounting for nearly 7% of total hospital admissions. Moreover, as per the National Center for Health Statistics, every year, 156,979 deaths occur due to Chronic lower respiratory diseases (including asthma) deaths in the United States. In the US, Lung cancer is the leading cause of cancer death in both men and women in the United States, and around two-thirds of persons diagnosed with lung cancer have never smoked or are former smokers. Over the last 42 years, new incidences of lung cancer have grown by 84% among women, while falling by 36% among males. Each year, lung cancer claims more lives than any other type of cancer report published by American Lung Association. The burden of CRDs is expected to increase in the coming future due to poor air quality, increase in addiction to smoking, and rise in geriatric population that is more prone to COPD and lung cancer. Moreover, programs initiated in the countries to improve treatment and support the people living with respiratory diseases are likely to increase the demand for PCR for the diagnosis of respiratory diseases. This will lead to the market growth during the forecast period.



Geographically, the PCR for respiratory infection diagnostics market is segmented into North America, Europe, Asia Pacific (APAC), the Middle East and Africa (MEA), and South and Central America (SCAM). Asia Pacific held the largest market share in 2020. In Asia Pacific, the China is the largest market for PCR for respiratory infection diagnostics market. The market growth in China is attributed to the key driving factors such as the increasing Burden of Chronic Respiratory Diseases (CRDs), growing developments in PCR testing, are widely enhancing the performance of medical devices. However, use of PCR testing for various respiratory infection diagnostics and developments in PCR technology being used to derive them. The availability of alternative assays hinders the market growth in China.



Thermo Fisher Scientific Inc.; Bio-Rad Laboratories Inc.; Abbott; F. Hoffmann-La Roche Ltd; Hologic, Inc.; Seegene Inc.; AusDiagnostics; BD; bioMérieux SA; and Qiagen are among the leading companies operating in the PCR for respiratory infection diagnostics market.



The report segments the pcr for respiratory infection diagnostics market as follows:


By Type


  • Real-Time PCR (qPCR)
  • Multiplex PCR
  • Traditional PCR
  • Digital PCR
  • Reverse-Transcriptase (RtoPCR)
  • Others

By Product Type


  • Reagents and Kits
  • Instruments
  • Others

By Infection Type


  • Bacterial Infections
  • Bordetella
  • Streptococcus Pneumoniae
  • Staphylococcus Aureus
  • Haemophilus Influenzae
  • Moraxella Catarrhalis
  • Mycoplasma Pneumoniae
  • Chlamydophila Pneumoniae
  • Legionella
  • Others
  • Viral Infections
  • Rhinoviruses
  • Influenza Virus
  • Severe Acute Respiratory Syndrome (SARS) CoV-2 Virus
  • Respiratory Syncytial Virus (RSV)
  • Adenovirus
  • Enterovirus
  • Parainfluenza
  • Human Metapneumovirus (hMPV)
  • Others
  • Fungal and Other Pathogens

By End User


  • Hospitals
  • Physician Clinics
  • Clinical Laboratories
  • Academic and Research Institutions
  • Biotech and Pharma Companies
  • Others

By Geography


  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • UK
  • Spain
  • Netherlands
  • Norway
  • Italy
  • Rest of Europe
  • Asia Pacific (APAC)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East and Africa (MEA)
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of Middle East and Africa
  • South and Central America (SCAM)
  • Brazil
  • Argentina
Rest of South and Central America


Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the PCR Respiratory Infection Diagnostics Market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global PCR Respiratory Infection Diagnostics Market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Frequently Asked Questions about the Global PCR for Respiratory Infection Diagnostic Market

What is the estimated value of the Global PCR for Respiratory Infection Diagnostic Market?

The Global PCR for Respiratory Infection Diagnostic Market was estimated to be valued at $4146.02 Million in 2021.

What is the growth rate of the Global PCR for Respiratory Infection Diagnostic Market?

The growth rate of the Global PCR for Respiratory Infection Diagnostic Market is 10.4%, with an estimated value of $8279.32 Million by 2028.

What is the forecasted size of the Global PCR for Respiratory Infection Diagnostic Market?

The Global PCR for Respiratory Infection Diagnostic Market is estimated to be worth $8279.32 Million by 2028.

Who are the key companies in the Global PCR for Respiratory Infection Diagnostic Market?

Key companies in the Global PCR for Respiratory Infection Diagnostic Market include Abbott, F. Hoffmann, La Roche AG, Hologic, Inc., Seegene Inc., AusDiagnostics, BD, Bio and BioMérieux.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 The Publisher's Research Report Guidance
1.3 Market Segmentation
1.3.1 Global PCR for Respiratory Infection Diagnostics Market - By Type
1.3.2 Global PCR for Respiratory Infection Diagnostics Market - By Product Type
1.3.3 Global PCR for Respiratory Infection Diagnostics Market - By Infection Type
1.3.4 Global PCR for Respiratory Infection Diagnostics Market - By End User
1.3.5 Global PCR for Respiratory Infection Diagnostics Market - By Geography
2. Global PCR for Respiratory Infection Diagnostics Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. PCR for Respiratory Infection Diagnostics Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East and Africa - PEST Analysis
4.2.5 South and Central America (SCAM) - PEST Analysis
4.3 Experts Opinion
5. PCR for Respiratory Infection Diagnostics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Burden of Chronic Respiratory Diseases (CRDs)
5.1.2 Growing Developments in PCR Testing
5.2 Market Restraints
5.2.1 Availability of Alternative Assays
5.3 Market Opportunities
5.3.1 Use of PCR Testing for Various Respiratory Infection Diagnostics
5.4 Future Trends
5.4.1 Developments in PCR Technology
5.5 Impact analysis
6. PCR for Respiratory Infection Diagnostics Market - Global Analysis
6.1 Global PCR for Respiratory Infection Diagnostics Market Revenue Forecast and Analysis
6.2 Global PCR for Respiratory Infection Diagnostics Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. PCR for Respiratory Infection Diagnostics Market Analysis By Type
7.1 Overview
7.2 PCR for Respiratory Infection Diagnostics Market Revenue Share, by Type (2021 and 2028)
7.3 Real Time PCR (qPCR)
7.3.1 Overview
7.3.2 Real Time PCR (qPCR): PCR for Respiratory Infection Diagnostics market - Revenue and Forecast to 2028 (US$ Million)
7.4 Multiplex PCR
7.4.1 Overview
7.4.2 Multiplex PCR: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Traditional PCR
7.5.1 Overview
7.5.2 Traditional PCR: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Digital PCR
7.6.1 Overview
7.6.2 Digital PCR: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.7 Reverse Transcriptase (RT-PCR)
7.7.1 Overview
7.7.2 Reverse Transcriptase (RT-PCR): PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
8. PCR for Respiratory Infection Diagnostics Market Analysis - By Product Type
8.1 Overview
8.2 PCR for Respiratory Infection Diagnostics Market, by Product Type 2021 & 2028 (%)
8.3 Reagents and kits
8.3.1 Overview
8.3.2 Reagents and Kits: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Instruments
8.4.1 Overview
8.4.2 Instruments: PCR for respiratory infection diagnostics market - Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9. PCR for Respiratory Infection Diagnostics Market - By Infection Type
9.1 Overview
9.2 PCR for Respiratory Infection Diagnostics Market Revenue Share, by Infection Type, 2021 & 2028 (%)
9.3 Bacterial Infections
9.3.1 Overview
9.3.2 Bacterial Infection: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028
9.3.3 (USD Million)
9.3.4 Bordetella
9.3.4.1 Overview
9.3.4.2 Bordetella: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.5 Streptococcus Pneumoniae
9.3.5.1 Overview
9.3.5.2 Streptococcus Pneumoniae: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.6 Staphylococcus Aureus
9.3.6.1 Overview
9.3.6.2 Staphylococcus Aureus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.7 Haemophilus Influenzae
9.3.7.1 Overview
9.3.7.2 Haemophilus Influenzae: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.8 Moraxella Catarrhalis
9.3.8.1 Overview
9.3.8.2 Moraxella Catarrhalis: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.9 Mycoplasma Pneumoniae
9.3.9.1 Overview
9.3.9.2 Mycoplasma Pneumoniae: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.10 Chlamydophila Pneumoniae
9.3.10.1 Overview
9.3.10.2 Chlamydophila Pneumoniae: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.11 Legionella
9.3.11.1 Overview
9.3.11.2 Legionella: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.12 Others
9.3.12.1 Overview
9.3.12.2 Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4 Viral Infection
9.4.1 Overview
9.4.2 Viral Infection: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.3 Rhinoviruses
9.4.3.1 Overview
9.4.3.2 Rhinoviruses: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.4 Influenza Virus
9.4.4.1 Overview
9.4.4.2 Influenza Virus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.5 Severe Acute Respiratory Syndrome (SARS) CoV-2 Virus
9.4.5.1 Overview
9.4.5.2 Severe Acute Respiratory Syndrome (SARS) CoV-2 Virus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.6 Respiratory Syncytial Virus (RSV)
9.4.6.1 Overview
9.4.6.2 Respiratory Syncytial Virus (RSV): PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.7 Adenovirus
9.4.7.1 Overview
9.4.7.2 Adenovirus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.8 Enterovirus
9.4.8.1 Overview
9.4.8.2 Enterovirus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.9 Parainfluenza
9.4.9.1 Overview
9.4.9.2 Parainfluenza: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.10 Human Metapneumovirus (hMPV)
9.4.10.1 Overview
9.4.10.2 Human Metapneumovirus (hMPV): PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.11 Others
9.4.11.1 Overview
9.4.11.2 Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.5 Fungal and Other Pathogens
9.5.1 Overview
9.5.2 Fungal and Other Pathogens: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10. PCR for Respiratory Infection Diagnostics Market - By End User
10.1 Overview
10.2 PCR for Respiratory Infection Diagnostics Market Revenue Share, by End User (2021 and 2028)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.4 Physician Clinics
10.4.1 Overview
10.4.2 Physician Clinics: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.5 Clinical Laboratories
10.5.1 Overview
10.5.2 Clinical Laboratories: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.6 Academic and Research Institutions
10.6.1 Overview
10.6.2 Academic and Research Institutions: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.7 Biotech and Pharma Companies
10.7.1 Overview
10.7.2 Biotech and Pharma Companies: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.8 Others
10.8.1 Overview
10.8.2 Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11. Global PCR for Respiratory Infection Diagnostics Market - Geographic Analysis
11.1 North America: PCR for Respiratory Infection Diagnostics Market
11.1.1 Overview
11.1.2 North America: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.3 North America: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
11.1.4 North America PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
11.1.5 North America PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
11.1.5.1 North America PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
11.1.5.2 North America: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections -Revenue and Forecast to 2028 (USD Million)
11.1.6 North America: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.1.7 North America: PCR for Respiratory Infection Diagnostics Market, by Country, 2021 & 2028 (%)
11.1.7.1 US: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.7.1.1 US: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.7.1.2 US: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
11.1.7.1.3 US: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
11.1.7.1.4 US: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
11.1.7.1.4.1 US: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
11.1.7.1.4.2 US: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
11.1.7.1.5 US: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.1.7.2 Canada: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.7.2.1 Canada: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.7.2.2 Canada: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
11.1.7.2.3 Canada: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
11.1.7.2.4 Canada: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
11.1.7.2.4.1 Canada: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
11.1.7.2.4.2 Canada: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
11.1.7.2.5 Canada: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.1.7.3 Mexico: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.7.3.1 Mexico: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.7.3.2 Mexico: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
11.1.7.3.3 Mexico: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
11.1.7.3.4 Mexico: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
11.1.7.3.4.1 Mexico: PCR for Respiratory Infection Diagnostics Market, by Viral Infection Type - Revenue and Forecast to 2028 (USD Million)
11.1.7.3.4.2 Mexico: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infection Type - Revenue and Forecast to 2028 (USD Million)
11.1.7.3.5 Mexico: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.2 Europe: PCR for Respiratory Infection Diagnostics Market
11.2.1 Overview
11.2.2 Europe: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.2.3 Europe: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
11.2.4 Europe: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
11.2.5 Europe: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
11.2.5.1 Europe: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
11.2.5.2 Europe: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
11.2.6 Europe: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.2.7 Europe: PCR for Respiratory Infection Diagnostics Market, by Country, 2021 & 2028 (%)
11.2.7.1 Germany: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.2.7.1.1 Germany: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.2.7.1.2 Germany: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
11.2.7.1.3 Germany: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
11.2.7.1.4 Germany: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
11.2.7.1.4.1 Germany: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
11.2.7.1.4.2 Germany: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
11.2.7.1.5 Germany: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.2.7.2 UK: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.2.7.2.1 UK: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.2.7.2.2 UK: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
11.2.7.2.3 UK: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
11.2.7.2.4 UK: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
11.2.7.2.4.1 UK: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
11.2.7.2.4.2 UK: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
11.2.7.2.5 UK: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.2.7.3 Norway: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.2.7.3.1 Norway: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.2.7.3.2 Norway: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
11.2.7.3.3 Norway: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
11.2.7.3.4 Norway: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
11.2.7.3.4.1 Norway: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
11.2.7.3.4.2 Norway: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
11.2.7.3.5 Norway: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.2.7.4 Netherlands: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.2.7.4.1 Netherlands: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.2.7.4.2 Netherlands: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
11.2.7.4.3 Netherlands: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
11.2.7.4.4 Netherlands: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
11.2.7.4.4.1 Netherlands: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
11.2.7.4.4.2 Netherlands: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
11.2.7.4.5 Netherlands: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.2.7.5 France: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.2.7.5.1 France: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.2.7.5.2 France: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
11.2.7.5.3 France: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
11.2.7.5.4 France: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
11.2.7.5.4.1 France: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
11.2.7.5.4.2 France: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
11.2.7.5.5 France: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.2.7.6 Italy: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.2.7.6.1 Italy: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.2.7.6.2 Italy: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
11.2.7.6.3 Italy: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
11.2.7.6.4 Italy: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
11.2.7.6.4.1 Italy: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
11.2.7.6.4.2 Italy: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
11.2.7.6.5 Italy: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.2.7.7 Spain: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.2.7.7.1 Spain: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.2.7.7.2 Spain: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
11.2.7.7.3 Spain: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
11.2.7.7.4 Spain: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
11.2.7.7.4.1 Spain: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
11.2.7.7.4.2 Spain: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
11.2.7.7.5 Spain: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.2.7.8 Rest of Europe: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.2.7.8.1 Rest of Europe: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.2.7.8.2 Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
11.2.7.8.3 Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
11.2.7.8.4 Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
11.2.7.8.4.1 Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
11.2.7.8.4.2 Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
11.2.7.8.5 Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.3 Asia Pacific: PCR for Respiratory Infection Diagnostics Market
11.3.1 Overview
11.3.2 Asia Pacific: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.3.3 Asia Pacific PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
11.3.4 Asia Pacific PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
11.3.5 Asia Pacific PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
11.3.5.1 Asia Pacific PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
11.3.5.2 Asia Pacific PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
11.3.6 Asia Pacific PCR for Respiratory Infection Diagnostics Market, By End Use - Revenue and Forecast to 2028 (USD Million)
11.3.7 Asia Pacific: PCR for Respiratory Infection Diagnostics Market, by Country, 2021 & 2028 (%)
11.3.7.1 China: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.3.7.1.1 China: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.3.7.1.2 China PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
11.3.7.1.3 China PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
11.3.7.1.4 China PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
11.3.7.1.4.1 China PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
11.3.7.1.4.2 China PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
11.3.7.1.5 China PCR for Respiratory Infection Diagnostics Market, By End Use - Revenue and Forecast to 2028 (USD Million)
11.3.7.2 Japan: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.3.7.2.1 Japan: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.3.7.2.2 Japan PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
11.3.7.2.3 Japan PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
11.3.7.2.4 Japan PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
11.3.7.2.4.1 Japan PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
11.3.7.2.4.2 Japan PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
11.3.7.2.5 Japan PCR for Respiratory Infection Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
11.3.7.3 India: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.3.7.3.1 India: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.3.7.3.2 India PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
11.3.7.3.3 India PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
11.3.7.3.4 India PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
11.3.7.3.4.1 India PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
11.3.7.3.4.2 India PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
11.3.7.3.5 India PCR for Respiratory Infection Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
11.3.7.4 South Korea: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.3.7.4.1 South Korea: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.3.7.4.2 South Korea PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
11.3.7.4.3 South Korea PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
11.3.7.4.4 South Korea PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
11.3.7.4.4.1 South Korea PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
11.3.7.4.4.2 South Korea PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
11.3.7.4.5 South Korea PCR for Respiratory Infection Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
11.3.7.5 Australia: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.3.7.5.1 Australia: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.3.7.5.2 Australia PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
11.3.7.5.3 Australia PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
11.3.7.5.4 Australia PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
11.3.7.5.4.1 Australia PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
11.3.7.5.4.2 Australia PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
11.3.7.5.5 Australia PCR for Respiratory Infection Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
11.3.7.6 Rest of Asia Pacific: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.3.7.6.1 Rest of Asia Pacific: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.3.7.6.2 Rest of Asia Pacific PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
11.3.7.6.3 Rest of Asia Pacific PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
11.3.7.6.4 Rest of Asia Pacific PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
11.3.7.6.4.1 Rest of Asia Pacific PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
11.3.7.6.4.2 Rest of Asia Pacific PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
11.3.7.6.5 Rest of Asia Pacific PCR for Respiratory Infection Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
11.4 Middle East & Africa: PCR for Respiratory Infection Diagnostics Market
11.4.1 Overview
11.4.2 Middle East & Africa: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.4.3 Middle East & Africa PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
11.4.4 Middle East & Africa PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
11.4.5 Middle East & Africa PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
11.4.5.1 Middle East & Africa PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
11.4.5.2 Middle East & Africa PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
11.4.6 Middle East & Africa PCR for Respiratory Infection Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
11.4.7 Middle East & Africa: PCR for Respiratory Infection Diagnostics Market, by Country, 2021 & 2028 (%)
11.4.7.1 Saudi Arabia: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.4.7.1.1 Saudi Arabia: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.4.7.1.2 Saudi Arabia PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
11.4.7.1.3 Saudi Arabia PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
11.4.7.1.4 Saudi Arabia PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
11.4.7.1.4.1 Saudi Arabia PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
11.4.7.1.4.2 Saudi Arabia PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
11.4.7.1.5 Saudi Arabia PCR for Respiratory Infection Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
11.4.7.2 UAE: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.4.7.2.1 UAE: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.4.7.2.2 UAE PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
11.4.7.2.3 UAE PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
11.4.7.2.4 UAE PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
11.4.7.2.4.1 UAE PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
11.4.7.2.4.2 UAE PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
11.4.7.2.5 UAE PCR for Respiratory Infection Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
11.4.7.3 South Africa: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.4.7.3.1 South Africa: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.4.7.3.2 South Africa PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
11.4.7.3.3 South Africa PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
11.4.7.3.4 South Africa PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
11.4.7.3.4.1 South Africa PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
11.4.7.3.4.2 South Africa PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
11.4.7.3.5 South Africa PCR for Respiratory Infection Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
11.4.7.4 Rest of Middle East & Africa: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.4.7.4.1 Rest of Middle East & Africa: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.4.7.4.2 Rest of Middle East & Africa PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
11.4.7.4.3 Rest of Middle East & Africa PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
11.4.7.4.4 Rest of Middle East & Africa PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
11.4.7.4.4.1 Rest of Middle East & Africa PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
11.4.7.4.4.2 Rest of Middle East & Africa PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
11.4.7.4.5 Rest of Middle East & Africa PCR for Respiratory Infection Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
11.5 South and Central America: PCR for Respiratory Infection Diagnostics Market
11.5.1 Overview
11.5.2 South and Central America: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.5.3 South and Central America: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
11.5.4 South and Central America: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
11.5.5 South and Central America: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
11.5.5.1 South and Central America: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
11.5.5.2 South and Central America: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
11.5.6 South and Central America: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.5.7 South and Central America: PCR for Respiratory Infection Diagnostics Market, by Country, 2021 & 2028 (%)
11.5.7.1 Brazil: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.5.7.1.1 Brazil: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.5.7.1.2 Brazil: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
11.5.7.1.3 Brazil: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
11.5.7.1.4 Brazil: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
11.5.7.1.4.1 Brazil: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
11.5.7.1.4.2 Brazil: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
11.5.7.1.5 Brazil: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.5.7.2 Argentina: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.5.7.2.1 Argentina: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.5.7.2.2 Argentina: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
11.5.7.2.3 Argentina: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
11.5.7.2.4 Argentina: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
11.5.7.2.4.1 Argentina: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
11.5.7.2.4.2 Argentina: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
11.5.7.2.5 Argentina: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.5.7.3 Rest of South and Central America: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.5.7.3.1 Rest of South and Central America: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.5.7.3.2 Rest of South and Central America: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
11.5.7.3.3 Rest of South and Central America: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
11.5.7.3.4 Rest of South and Central America: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
11.5.7.3.4.1 Rest of South and Central America: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
11.5.7.3.4.2 Rest of South and Central America: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
11.5.7.3.5 Rest of South and Central America: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
12. Impact Of COVID-19 Pandemic on PCR for Respiratory Infection Diagnostics Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12.5 South and Central America: Impact Assessment of COVID-19 Pandemic
13. PCR For Respiratory Infection Diagnostics Market-Industry Landscape
13.1 Overview
13.2 Growth Strategies in the PCR For Respiratory Infection Diagnostics Market, 2020-2021
13.3 Inorganic Growth Strategies
13.3.1 Overview
13.4 Organic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Abbott
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 F. HOFFMANN-LA ROCHE LTD.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Hologic, Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 BD
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 BIO-RAD LABORATORIES INC.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 bioMerieux SA
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 QIAGEN
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Thermo Fisher Scientific Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Seegene Inc
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 AusDiagnostics
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About the Publisher
15.2 Glossary of Terms
List of Tables
Table 1. North America PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 2. North America: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 3. North America: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 4. North America: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
Table 5. North America PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
Table 6. North America PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 7. US PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 8. US PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 9. US PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 10. US PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
Table 11. US PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
Table 12. US PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 13. Canada PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 14. Canada PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 15. Canada PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 16. Canada PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
Table 17. Canada PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
Table 18. Canada PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 19. Mexico PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 20. Mexico PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 21. Mexico PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 22. Mexico PCR for Respiratory Infection Diagnostics Market, by Viral Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 23. Mexico PCR for Respiratory Infection Diagnostics Market, by Bacterial Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 24. Mexico PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 25. Europe: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 26. Europe: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 27. Europe: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 28. Europe: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
Table 29. Europe: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
Table 30. Europe: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 31. Germany: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 32. Germany: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 33. Germany: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 34. Germany: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
Table 35. Germany: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
Table 36. Germany: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 37. UK: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 38. UK: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 39. UK: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 40. UK: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
Table 41. UK: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
Table 42. UK: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 43. Norway: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 44. Norway: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 45. Norway: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 46. Norway: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
Table 47. Norway: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
Table 48. Norway: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 49. Netherlands: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 50. Netherlands: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 51. Netherlands: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 52. Netherlands: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
Table 53. Netherlands: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
Table 54. Netherlands: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 55. France PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 56. France PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 57. France PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 58. France PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
Table 59. France PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
Table 60. France PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 61. Italy PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 62. Italy PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 63. Italy PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 64. Italy PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
Table 65. Italy PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
Table 66. Italy PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 67. Spain PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 68. Spain PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 69. Spain PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 70. Spain PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
Table 71. Spain PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
Table 72. Spain PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 73. Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 74. Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 75. Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 76. Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
Table 77. Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
Table 78. Rest of Europe: PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 79. Asia Pacific PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
Table 80. Asia Pacific PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
Table 81. Asia Pacific PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 82. Asia Pacific PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
Table 83. Asia Pacific PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
Table 84. Asia Pacific PCR for Respiratory Infection Diagnostics Market, By End Use - Revenue and Forecast to 2028 (USD Million)
Table 85. China PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
Table 86. China PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
Table 87. China PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 88. China PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
Table 89. China PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
Table 90. China PCR for Respiratory Infection Diagnostics Market, By End Use - Revenue and Forecast to 2028 (USD Million)
Table 91. Japan PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
Table 92. Japan PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
Table 93. Japan PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 94. Japan PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
Table 95. Japan PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
Table 96. Japan PCR for Respiratory Infection Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 97. India PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
Table 98. India PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
Table 99. India PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 100. India PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
Table 101. India PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
Table 102. India PCR for Respiratory Infection Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 103. South Korea PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
Table 104. South Korea PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
Table 105. South Korea PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 106. South Korea PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
Table 107. South Korea PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
Table 108. South Korea PCR for Respiratory Infection Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 109. Australia PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
Table 110. Australia PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
Table 111. Australia PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 112. Australia PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
Table 113. Australia PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
Table 114. Australia PCR for Respiratory Infection Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 115. Rest of Asia Pacific PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
Table 116. Rest of Asia Pacific PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
Table 117. Rest of Asia Pacific PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 118. Rest of Asia Pacific PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
Table 119. Rest of Asia Pacific PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
Table 120. Rest of Asia Pacific PCR for Respiratory Infection Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 121. Middle East & Africa PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
Table 122. Middle East & Africa PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
Table 123. Middle East & Africa PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 124. Middle East & Africa PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
Table 125. Middle East & Africa PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
Table 126. Middle East & Africa PCR for Respiratory Infection Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 127. Saudi Arabia PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
Table 128. Saudi Arabia PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
Table 129. Saudi Arabia PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 130. Saudi Arabia PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
Table 131. Saudi Arabia PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
Table 132. Saudi Arabia PCR for Respiratory Infection Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 133. UAE PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
Table 134. UAE PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
Table 135. UAE PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 136. UAE PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
Table 137. UAE PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
Table 138. UAE PCR for Respiratory Infection Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 139. South Africa PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
Table 140. South Africa PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
Table 141. South Africa PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 142. South Africa PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
Table 143. South Africa PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
Table 144. South Africa PCR for Respiratory Infection Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 145. Rest of Middle East & Africa PCR for Respiratory Infection Diagnostics Market, By Type - Revenue and Forecast to 2028 (USD Million)
Table 146. Rest of Middle East & Africa PCR for Respiratory Infection Diagnostics Market, By Product Type - Revenue and Forecast to 2028 (USD Million)
Table 147. Rest of Middle East & Africa PCR for Respiratory Infection Diagnostics Market, By Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 148. Rest of Middle East & Africa PCR for Respiratory Infection Diagnostics Market, By Viral Infection - Revenue and Forecast to 2028 (USD Million)
Table 149. Rest of Middle East & Africa PCR for Respiratory Infection Diagnostics Market, By Bacterial Infection - Revenue and Forecast to 2028 (USD Million)
Table 150. Rest of Middle East & Africa PCR for Respiratory Infection Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 151. South and Central America PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 152. South and Central America PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 153. South and Central America PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 154. South and Central America PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
Table 155. South and Central America PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
Table 156. South and Central America PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 157. Brazil PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 158. Brazil PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 159. Brazil PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 160. Brazil PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
Table 161. Brazil PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
Table 162. Brazil PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 163. Argentina PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 164. Argentina PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 165. Argentina PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 166. Argentina PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
Table 167. Argentina PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
Table 168. Argentina PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 169. Rest of South and Central America PCR for Respiratory Infection Diagnostics Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 170. Rest of South and Central America PCR for Respiratory Infection Diagnostics Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
Table 171. Rest of South and Central America PCR for Respiratory Infection Diagnostics Market, by Infection Type - Revenue and Forecast to 2028 (USD Million)
Table 172. Rest of South and Central America PCR for Respiratory Infection Diagnostics Market, by Viral Infections - Revenue and Forecast to 2028 (USD Million)
Table 173. Rest of South and Central America PCR for Respiratory Infection Diagnostics Market, by Bacterial Infections - Revenue and Forecast to 2028 (USD Million)
Table 174. Rest of South and Central America PCR for Respiratory Infection Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 175. Recent Inorganic Growth Strategies in the PCR for Respiratory Infection Diagnostics Market
Table 176. Recent Organic Growth Strategies in the PCR for Respiratory Infection Diagnostics Market
Table 177. Glossary of Terms, PCR for Respiratory Infection Diagnostics Market
List of Figures
Figure 1. PCR for Respiratory Infection Diagnostics Market Segmentation
Figure 2. PCR for Respiratory Infection Diagnostics Market Segmentation, By Region
Figure 3. Global PCR for Respiratory Infection Diagnostics Market Overview
Figure 4. Real-Time PCR (qPCR) Segment Held Largest Share of Type Segment in PCR for Respiratory Infection Diagnostics Market
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. PCR for Respiratory Infection Diagnostics Market, by Geography (US$ Million)
Figure 7. Global PCR for Respiratory Infection Diagnostics Market - Leading Country Markets (US$ Million)
Figure 8. Global PCR for Respiratory Infection Diagnostics Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe and PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. PCR for Respiratory Infection Diagnostics Market Impact Analysis of Driver and Restraints
Figure 15. Global PCR for Respiratory Infection Diagnostics Market - Revenue Forecast and Analysis - 2020- 2028
Figure 16. Global PCR for Respiratory Infection Diagnostics Market - By Geography Forecast and Analysis - 2021- 2028
Figure 17. Market Positioning of Key Players in Global PCR for Respiratory Infection Diagnostics Market
Figure 18. PCR for Respiratory Infection Diagnostics Market Revenue Share, by Type (2021 and 2028)
Figure 19. Real Time PCR (qPCR): PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Multiplex PCR: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Traditional PCR: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Digital PCR: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Reverse Transcriptase (RT-PCR): PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. PCR for Respiratory Infection Diagnostics Market, by Product Type 2021 & 2028 (%)
Figure 26. Reagents and Kits: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Instruments: PCR for respiratory infection diagnostics market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. PCR for Respiratory Infection Diagnostics Market Share, by Infection Type, 2021 & 2028 (%)
Figure 30. Bacterial Infection: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 31. Bordetella: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 32. Streptococcus Pneumoniae: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 33. Staphylococcus Aureus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 34. Haemophilus Influenzae: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 35. Moraxella Catarrhalis: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 36. Mycoplasma Pneumoniae: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 37. Chlamydophila Pneumoniae: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 38. Legionella: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 39. Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 40. Viral Infection: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 41. Rhinoviruses: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 42. Influenza Virus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 43. Severe Acute Respiratory Syndrome (SARS) CoV-2 Virus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 44. Respiratory Syncytial Virus (RSV): PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 45. Adenovirus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 46. Enterovirus: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 47. Parainfluenza: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 48. Human Metapneumovirus (hMPV): PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 49. Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 50. Fungal and Other Pathogens: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 51. PCR for Respiratory Infection Diagnostics Market Share, by End User, 2021 and 2028 (%)
Figure 52. Hospitals: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 53. Physician Clinics: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 54. Clinical Laboratories: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 55. Academic and Research Institutions: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 56. Biotech and Pharma Companies: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 57. Others: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 58. North America: PCR for Respiratory Infection Diagnostics Market, by Key Country - Revenue (2021) (USD Million)
Figure 59. North America PCR for Respiratory Infection Diagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 60. North America: PCR for Respiratory Infection Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 61. US: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 62. Canada: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 63. Mexico: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 64. Europe: PCR for Respiratory Infection Diagnostics Market, by Key Country - Revenue (2021) (USD Million)
Figure 65. Europe: PCR for Respiratory Infection Diagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 66. Europe: PCR for Respiratory Infection Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 67. Germany: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 68. UK: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 69. Norway: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 70. Netherlands: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 71. France: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 72. Italy: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 73. Spain: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 74. Rest of Europe: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 75. Asia Pacific: PCR for Respiratory Infection Diagnostics Market, by Key Country - Revenue (2021) (USD Million)
Figure 76. Asia Pacific PCR for Respiratory Infection Diagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 77. Asia Pacific: PCR for Respiratory Infection Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 78. China: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 79. Japan: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 80. India: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 81. South Korea: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 82. Australia: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 83. Rest of Asia Pacific: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 84. Middle East & Africa: PCR for Respiratory Infection Diagnostics Market, by Key Country - Revenue (2021) (USD Million)
Figure 85. Middle East & Africa PCR for Respiratory Infection Diagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 86. Middle East & Africa: PCR for Respiratory Infection Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 87. Saudi Arabia: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 88. UAE: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 89. South Africa: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 90. Rest of Middle East & Africa: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 91. South and Central America: PCR for Respiratory Infection Diagnostics Market, by Key Country - Revenue (2021) (USD Million)
Figure 92. South and Central America PCR for Respiratory Infection Diagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 93. South and Central America: PCR for Respiratory Infection Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 94. Brazil: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 95. Argentina: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 96. Rest of South and Central America: PCR for Respiratory Infection Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 97. Impact of COVID-19 Pandemic in North American Country Markets
Figure 98. Impact of COVID-19 Pandemic in European Country Markets
Figure 99. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 100. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 101. Impact of COVID-19 Pandemic in South and Central America Country Markets
Figure 102. Growth Strategies in the PCR For Respiratory Infection Diagnostics Market, 2020-2021

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Seegene Inc.
  • AusDiagnostics
  • BD
  • Bio-Rad Laboratories Inc
  • BioMérieux
  • Qiagen
  • Thermo Fisher Scientific Inc